News | October 30, 2022
Granules India plans H2 FY 2022-23 R&D spend in Rs. 80-90 Cr
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The company's long-term strategy is on science, technology and innovation and the company's strategy relating to this is on track
The newest facility has all the core specialties like Obstetrics and Gynaecology, Orthopaedics, Neurology, Cardiology, Paediatrics, General Surgery, and Urology
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
The inspection concluded with no observation (FDA-483) issued.
Sildenafil for Oral Suspension had annual sales of USD 65 million in the United States according to IQVIA data (IQVIA MAT Aug 2022).
Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US
The company will address the observations within a stipulated timeline working with the regulators
This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
Subscribe To Our Newsletter & Stay Updated
